within Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A10B_BloodGlucoseLoweringDrugsExclInsulins.A10BX01_GuarGum;

model GuarGum
  extends Pharmacolibrary.Drugs.ATC.A.A10BX01;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>A10BX01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Guar gum is a water-soluble dietary fiber derived from the guar bean (Cyamopsis tetragonoloba), primarily used as a food thickening and stabilizing agent. It has been studied as an adjunct for glycemic control in type 2 diabetes mellitus due to its ability to delay glucose absorption. Guar gum is not approved as a drug for treating diabetes and is mainly used as a food additive today.</p><h4>Pharmacokinetics</h4><p>No direct pharmacokinetic parameters are reported in the literature for guar gum in humans, as it is minimally absorbed systemically and primarily exerts local effects in the gut after oral administration. Thus, the following values are estimated or not applicable.</p><h4>References</h4><ol><li><p>Scheen, AJ (1996). Clinical pharmacokinetics of metformin. <i>Clinical pharmacokinetics</i> 30(5) 359–371. DOI:<a href=&quot;https://doi.org/10.2165/00003088-199630050-00003&quot;>10.2165/00003088-199630050-00003</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8743335/&quot;>https://pubmed.ncbi.nlm.nih.gov/8743335</a></p></li><li><p>Kaur, M, et al., &amp; Goyal, AK (2015). Development and characterization of guar gum nanoparticles for oral immunization against tuberculosis. <i>Drug delivery</i> 22(3) 328–334. DOI:<a href=&quot;https://doi.org/10.3109/10717544.2014.894594&quot;>10.3109/10717544.2014.894594</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/24611942/&quot;>https://pubmed.ncbi.nlm.nih.gov/24611942</a></p></li><li><p>Krishnaiah, YS, et al., &amp; Bhaskar, P (2003). In vivo pharmacokinetics in human volunteers: oral administered guar gum-based colon-targeted 5-fluorouracil tablets. <i>European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences</i> 19(5) 355–362. DOI:<a href=&quot;https://doi.org/10.1016/s0928-0987(03)00139-8&quot;>10.1016/s0928-0987(03)00139-8</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/12907286/&quot;>https://pubmed.ncbi.nlm.nih.gov/12907286</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end GuarGum;
